海利品牌怎么样 申请店铺

我要投票 海利在兽药行业中的票数:339 更新时间:2025-07-11
海利是哪个国家的品牌?「海利」是 上海海利生物技术股份有限公司 旗下著名品牌。该品牌发源于上海,由创始人张海明在1981期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力海利品牌出海!将品牌入驻外推网,定制海利品牌推广信息,可以显著提高海利产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

海利怎么样

上海海利生物技术股份有限公司(以下简称“海利生物”)位于上海奉贤经济开发区金海路6720号,其前身为上海松江生物药品厂,是农业部在上海批准生产兽用生物制品的定点企业及农业部在上海设立的动物重大疫情防治生产基地。作为一家专业的动物保健品公司,海利生物能够为预防动物疾病、改善动物福利和提高养殖业主的生产效益提供综合解决方案。海利生物的产品和服务涵盖了家畜、家禽以及宠物等多个领域。

海利生物是上海市高新技术企业、上海市农业产业化重点龙头企业、上海兽用生物制品工程技术研究中心、上海市科技小巨人(培育)企业;海利生物商标被认定为上海市著名商标,公司的疫苗产品荣获“上海名牌”称号;海利生物为上海农林职业技术学院(生物技术专业)的实习培训基地。

海利生物拥有11条GMP生产线,自主生产家畜、家禽两大系列共40多个产品。多年来,海利生物坚持科技创新之路,以市场为导向、以产品为依托,销售网络遍布全国,销售业绩成倍增长。海利生物现有员工近450名,其中专业技术人员占50%以上。海利生物坚持以人为本的人才战略,已建立起经营高效的管理团队、技术精湛的研发团队以及技能娴熟的员工团队。

在企业快速发展中,海利生物高度重视产、学、研相结合的产品战略,以市场为导向,几年来先后与国内行业领先的中国科学院、中国农科院哈尔滨兽医研究所、南京农业大学、河南农业大学等科研机构合作,共同开发具有国内外先进水平的兽用生物疫苗。特别是拥有了猪繁殖与呼吸综合征活疫苗(即蓝耳病活疫苗)、猪圆环病毒2型灭活疫苗(LG株)、猪传染性胃肠炎和流行性腹泻二联灭活疫苗、猪链球菌二联灭活疫苗、鸡新城疫/传染性支气管炎/减蛋综合征/禽流感(H9N2)四联灭活疫苗等国家一、二类新药的知识产权,其中多个新产品的研发及产业化项目获得了上海市科委、上海市经委的科技创新项目立项支持。海利生物的猪繁殖与呼吸综合征活疫苗(即蓝耳病活疫苗)、猪传染性胃肠炎和流行性腹泻二联灭活疫苗、猪圆环病毒2型灭活疫苗、猪链球菌灭活疫苗、高致病性猪繁殖与呼吸综合征活疫苗已先后被认定为上海市科委高新技术成果转化项目,猪链球菌二联灭活疫苗荣获上海市科技进步二等奖。尤其从2007年开始,在全国范围内爆发的猪蓝耳病疫情防治工作中,海利生物承担了农业部定点生产高致病性猪蓝耳病疫苗的重要任务,为广大养殖户提供优质、可靠的疫苗,及时有效地防控了疫情的蔓延。

海利生物致力于为预防畜禽疾病、改善畜禽健康和提高养殖业主的生产效益服务,并能够提供综合解决方案和权威的兽医专家服务系统。为满足市场需求,海利生物一如既往地坚持自主创新及高新技术产业化发展的战略重点,力争跻身国内兽用生物疫苗行业前列。



Shanghai Haili Biotechnology Co., Ltd. (hereinafter referred to as "Haili biology") is located at No. 6720, Jinhai Road, Fengxian Economic Development Zone, Shanghai. Its predecessor is Shanghai Songjiang biological medicine factory. It is a designated enterprise approved by the Ministry of agriculture to produce biological products for animal use in Shanghai and a production base for animal major epidemic prevention and control established by the Ministry of agriculture in Shanghai. As a professional animal health products company, Haili bio can provide comprehensive solutions for preventing animal diseases, improving animal welfare and improving the production efficiency of breeding owners. Haili's products and services cover livestock, poultry and pets. Haili biology is a high-tech enterprise in Shanghai, a key leading enterprise of agricultural industrialization in Shanghai, a research center of animal biological products engineering technology in Shanghai, and a small giant (cultivation) enterprise of science and technology in Shanghai. Haili biology trademark is recognized as a famous trademark in Shanghai, The company's vaccine products won the title of "Shanghai famous brand"; Haili biology is the practice training base of Shanghai Agricultural and Forestry Vocational Technical College (Biotechnology Major). Haili biological has 11 GMP production lines, and independently produces more than 40 products in two series of livestock and poultry. Over the years, Haili biology adheres to the road of scientific and technological innovation, is market-oriented and product-based, with its sales network all over the country, and its sales performance has multiplied. Haili biology has nearly 450 employees, of which more than 50% are professional technicians. Haili biology adheres to the human-oriented talent strategy and has established an efficient management team, a skilled R & D team and a skilled staff team. In the rapid development of the enterprise, Haili biology attaches great importance to the product strategy of combining production, learning and research, and is market-oriented. In recent years, Haili biology has cooperated with Chinese Academy of Sciences, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Nanjing Agricultural University, Henan Agricultural University and other scientific research institutions to jointly develop animal biological vaccines with advanced level at home and abroad. In particular, it has the knowledge production of the first and second class new drugs in China, such as the live vaccine of porcine reproductive and respiratory syndrome (i.e. the live vaccine of blue ear disease), the inactivated vaccine of porcine circovirus type 2 (LG strain), the inactivated vaccine of swine infectious gastroenteritis and epidemic diarrhea, the inactivated vaccine of Streptococcus suis, the inactivated vaccine of Newcastle disease / infectious bronchitis / egg drop syndrome / avian influenza (H9N2), etc Among them, R & D and industrialization projects of many new products have been supported by science and technology innovation projects of Shanghai Municipal Commission of science and technology and Shanghai Economic Commission. Haili bio's live vaccine for porcine reproductive and respiratory syndrome (i.e. live vaccine for blue ear disease), bivalent inactivated vaccine for transmissible gastroenteritis and epidemic diarrhea, bivalent inactivated vaccine for porcine circovirus type 2, Streptococcus suis, and highly pathogenic live vaccine for porcine reproductive and respiratory syndrome have been successively recognized as the high-tech achievement transformation project of Shanghai Science and Technology Commission, bivalent inactivated vaccine for Streptococcus suis Won the second prize of Shanghai Science and technology progress award. Especially since 2007, in the prevention and control of the outbreak of blue ear disease nationwide, Haili biology has undertaken the important task of producing highly pathogenic blue ear disease vaccine designated by the Ministry of agriculture, providing high-quality and reliable vaccine for the majority of farmers, and preventing and controlling the spread of the disease in time and effectively. Haili biology is committed to the prevention of livestock and poultry diseases, improve the health of livestock and poultry and improve the production efficiency of breeding owners, and can provide comprehensive solutions and authoritative veterinary expert service system. In order to meet the market demand, Haili biology, as always, adheres to the strategic focus of independent innovation and the development of high-tech industrialization, and strives to be in the forefront of domestic veterinary biological vaccine industry.

本文链接: https://brand.waitui.com/5c9756dfe.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

受中东冲突影响,英国伦敦希思罗机场6月份客运量下降

英国伦敦希思罗机场(Heathrow Airport) 6月份客运量有所下降,但今年前六个月的客运量仍达到创纪录的3990万人次。希思罗机场称,上个月客运量同比下降1%,至730万人次,其中,由于中东地区发生冲突,中东旅客人数下滑5.9%。来自拉丁美洲和北美洲的旅客人数分别减少3.8%和3.3%。与此同时,来自非洲和欧盟的旅客人数分别增长1.9%和1.6%。(新浪财经)

40分钟前

步步高投资集团显示经营异常

36氪获悉, 爱企查App显示,近日,步步高投资集团股份有限公司因未按照规定期限公示年度报告,被湘潭市市场监督管理局列入经营异常名录。步步高投资集团股份有限公司立于2003年2月,法定代表人为王填,注册资本约12.18亿元人民币,经营范围包括投资及财务咨询服务、房地产信息咨询服务、商务信息咨询服务等。股东信息显示,该公司由王填、长沙高晟投资合伙企业(有限合伙)等共同持股。

40分钟前

外交部:持续简化签证申请手续,外国朋友的“中国游”更加顺畅丝滑

7月11日外交部发言人毛宁主持例行记者会,有记者问:美国《华盛顿邮报》、“旅行与旅游世界”网站等媒体日前刊文称,中国免签政策有助于展示悠久历史和“赛博朋克”的炫酷,向世界展示了中国的活力,这与近期一些国家收紧签证、日趋封闭形成对比,请问发言人对此有何看法?毛宁表示,中国单方面免签和过境免签国家已经分别扩大到47个和55个。我们持续简化签证申请手续,实施“一站式”入境服务和离境退税“即买即退”。外国朋友的“中国游”更加顺畅丝滑。“脱钩断链”、封闭排他不是中国的选项,我们将继续以实际行动扩大高水平对外开放,与各国共享机遇、共创未来。(央视新闻)

40分钟前

特斯拉正式进军印度市场,孟买体验中心7月15日开业

特斯拉在孟买开设的印度首个展厅下周开业,此前该公司已进口价值100万美元的汽车及周边商品,这标志着特斯拉进军世界第三大汽车市场,尽管首席执行官马斯克抱怨印度进口关税高。特斯拉在周四晚些时候向媒体发出的邀请函中表示,7月15日位于孟买核心商业区班德拉库尔拉综合体(Bandra Kurla Complex)的特斯拉体验中心开业,从而启动印度市场业务。(新浪财经)

40分钟前

三六零:预计上半年净亏损2.4亿元-3.2亿元

36氪获悉,三六零公告,预计上半年净亏损2.4亿元-3.2亿元,上年同期亏损3.41亿元。报告期内,公司业绩预亏的原因主要系公司为加强产品宣传、扩大市场影响,销售费用投入增加。

40分钟前

本页详细列出关于海利的品牌信息,含品牌所属公司介绍,海利所处行业的品牌地位及优势。
咨询